These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28643861)

  • 1. Challenges in the Development of Novel Cardiovascular Therapies.
    Hwang TJ; Kesselheim AS
    Clin Pharmacol Ther; 2017 Aug; 102(2):194-196. PubMed ID: 28643861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why So Few New Cardiovascular Drugs Translate to the Clinics.
    Vatner SF
    Circ Res; 2016 Sep; 119(6):714-7. PubMed ID: 27587410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data Mining as a Powerful Tool for Creating Novel Drugs in Cardiovascular Medicine: The Importance of a "Back-and-Forth Loop" Between Clinical Data and Basic Research.
    Kitakaze M; Asakura M; Nakano A; Takashima S; Washio T
    Cardiovasc Drugs Ther; 2015 Jun; 29(3):309-15. PubMed ID: 26095683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occlusion in the Flow of New Drugs for Cardiovascular Disease.
    Ringel MS; Shah NA; Baedeker M; Lim CT; Lamichhane A; Schulze U
    Clin Pharmacol Ther; 2017 Aug; 102(2):246-253. PubMed ID: 28378877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.
    Povsic TJ; Scott R; Mahaffey KW; Blaustein R; Edelberg JM; Lefkowitz MP; Solomon SD; Fox JC; Healy KE; Khakoo AY; Losordo DW; Malik FI; Monia BP; Montgomery RL; Riesmeyer J; Schwartz GG; Zelenkofske SL; Wu JC; Wasserman SM; Roe MT
    Cardiovasc Drugs Ther; 2017 Aug; 31(4):445-458. PubMed ID: 28735360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular pipeline decline quantified.
    Mullard A
    Nat Rev Drug Discov; 2016 Sep; 15(10):669. PubMed ID: 27681785
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular pharmacotherapy: Innovation stuck in translation.
    Rongen GA; Wever KE
    Eur J Pharmacol; 2015 Jul; 759():200-4. PubMed ID: 25814253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular pharmacology in the post-blockbuster era.
    Brandes RP
    Curr Opin Pharmacol; 2010 Apr; 10(2):109-10. PubMed ID: 20202904
    [No Abstract]   [Full Text] [Related]  

  • 9. Connections in pharmacology: innovation serving translational medicine.
    Montero-Melendez T; Perretti M
    Drug Discov Today; 2014 Jul; 19(7):820-3. PubMed ID: 24316023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Future of Cardiovascular Therapeutics.
    MacRae CA; Roden DM; Loscalzo J
    Circulation; 2016 Jun; 133(25):2610-7. PubMed ID: 27324356
    [No Abstract]   [Full Text] [Related]  

  • 11. Partnering for therapeutics discovery.
    Colvis CM; Devaney S; Brady LS; Hudson KL
    Clin Pharmacol Ther; 2013 Jan; 93(1):24-5. PubMed ID: 23187876
    [No Abstract]   [Full Text] [Related]  

  • 12. Affairs of the Heart: Innovation in Cardiovascular Research and Development.
    Honig P; Terzic A
    Clin Pharmacol Ther; 2017 Aug; 102(2):162-168. PubMed ID: 28718903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics to Revive Drug Development in Cardiovascular Disease.
    Dubé MP; de Denus S; Tardif JC
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):59-64. PubMed ID: 26768480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational Research and Drug Discovery for Neurodegeneration: Challenges for Latin America.
    Rao KSJ; Britton GB; Rocha Arrieta LL; Garcia-Cairasco N; Lazarowski A; Palacios A; Camins Espuny A; Maccioni RB
    J Alzheimers Dis; 2021; 82(s1):S1-S4. PubMed ID: 34092644
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.
    Bellinger AM; Arteaga CL; Force T; Humphreys BD; Demetri GD; Druker BJ; Moslehi JJ
    Circulation; 2015 Dec; 132(23):2248-58. PubMed ID: 26644247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discovery in a multidimensional world: systems, patterns, and networks.
    Dudley JT; Schadt E; Sirota M; Butte AJ; Ashley E
    J Cardiovasc Transl Res; 2010 Oct; 3(5):438-47. PubMed ID: 20677029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translatability: what does it mean in drug discovery?
    Tudor M; Hermes J; Li J
    Drug Discov Today; 2016 Jun; 21(6):865-7. PubMed ID: 27021791
    [No Abstract]   [Full Text] [Related]  

  • 18. Translational paradigms in pharmacology and drug discovery.
    Mullane K; Winquist RJ; Williams M
    Biochem Pharmacol; 2014 Jan; 87(1):189-210. PubMed ID: 24184503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary on R&D Trends Away from General Medicine/Cardiovascular Drugs: Can the FDA Help Reverse the Trend?
    Meyer RJ
    Clin Pharmacol Ther; 2017 Aug; 102(2):186-188. PubMed ID: 28636269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro diagnostics in the development and use of cardiovascular medicines.
    Leadley RJ
    Curr Opin Mol Ther; 2010 Dec; 12(6):639-46. PubMed ID: 21154155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.